A small but significant new study showed low doses of Ozempic helped people to drink less. Scientists are starting to ...

Semaglutide — the active substance in Ozempic and Wegovy — may help reduce alcohol cravings in people with alcohol use ...

Adults with type 2 diabetes may have a higher risk for developing nonarteritic anterior ischemic optic neuropathy while using ...

New research suggests semaglutide, marketed as Ozempic for diabetes and Wegovy for obesity, could help people reduce their alcohol consumption.

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

More than three dozen attorneys general are urging the FDA to take “decisive action” against counterfeit obesity drugs.

A 52-year-old man has knocked his decade-long cocaine addiction on the head after receiving weight-loss injections. The jab ...

Semaglutide, known as Ozempic, may reduce alcohol cravings and consumption, offering new addiction treatment possibilities.

Ozempic is synonymous with weight loss for many people. Doctors explain benefits and risks of semaglutide and other GLP-1 ...

Two Omaha women lost more than 300 lbs. combined with injections of a GLP-1 drug, which are used increasingly for weight loss ...

The new study looked at one of these drugs, semaglutide, which is the drug in Ozempic and Wegovy. The research, published ...

A new clinical trial showed promising results in curbing alcohol cravings in individuals with moderate alcohol-use disorder.